Share useful research with your peers
in · Share on LinkedIn ↗
COMPANY RESEARCH

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Fosun Pharmaceutical is a Chinese healthcare group with research, development, manufacturing and commercialization activities across pharmaceutical medicines and related healthcare businesses. Its innovative therapeutics work includes small-molecule drugs, biological medicines and collaborative development programs in oncology and other disease areas. The issuer is traded on both the Shanghai Stock Exchange and the Hong Kong Stock Exchange, which should be represented as two securities of a single listed group. Fosun Pharma also has businesses outside proprietary drug development, so the directory distinguishes its therapeutics activities from its wider corporate portfolio.

Company at a glance

Corporate information

Company entity
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Founded
Not verified
Ownership / capital status
Publicly tradedPublicly listed
LinkedIn company page
Independent company page not verified

Profile review: 2026-11-08 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.

Listed issuer and R&D focus

SSE: 600196 HKEX: 02196

small molecules · antibody biologics · cell therapy

oncology · immunology · infectious diseases

Last independently verified:

Disease tags match recorded text mentions and require program-level verification.

Technology, programs & evidence

Shanghai Fosun Pharmaceutical is a Chinese healthcare group with research, development, manufacturing and commercialization activities across pharmaceutical medicines and related healthcare businesses. Its innovative therapeutics work includes small-molecule drugs, biological medicines and collaborative development programs in oncology and other disease areas. The issuer is traded on both the Shanghai Stock Exchange and the Hong Kong Stock Exchange, which should be represented as two securities of a single listed group. Fosun Pharma also has businesses outside proprietary drug development, so the directory distinguishes its therapeutics activities from its wider corporate portfolio.

Business, technology & evidence

  • SecuritiesSSE: 600196 / HKEX: 02196

Individual program detail is not recorded. Consult the original sources below.

Related news & literature

Company-name matches are discovery leads; verify entity identity and transaction roles in the original source.

Showing 0 / 0 related items

No cataloged update explicitly mentions this company.

Same-field reading (not company-specific)

Research this company together

Discussions are for signed-in members. Personal notes remain separate from company research.

Sign in to join

Sources & open questions

    1. Official issuer and R&D disclosure · Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ↗Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ·
    2. Official issuer and R&D disclosure · Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ↗Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ·

    Inclusion is not endorsement or partner qualification. Assess company claims, clinical evidence, and project-specific capabilities separately.

    AI assistant ↗